Cargando…
Whole Soy Flour Incorporated into a Muffin and Consumed at 2 Doses of Soy Protein Does Not Lower LDL Cholesterol in a Randomized, Double-Blind Controlled Trial of Hypercholesterolemic Adults(1)(2)
Background: Soy protein may reduce coronary heart disease (CHD) risk by lowering LDL cholesterol, but few studies have assessed whether whole soy flour displays a similar effect. Objective: The aim of this study was to assess the dose effect of whole soy flour incorporated into muffins on plasma LDL...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Nutrition
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656908/ https://www.ncbi.nlm.nih.gov/pubmed/26446482 http://dx.doi.org/10.3945/jn.115.219873 |
_version_ | 1782402294635036672 |
---|---|
author | Padhi, Emily MT Blewett, Heather J Duncan, Alison M Guzman, Randolph P Hawke, Aileen Seetharaman, Koushik Tsao, Rong Wolever, Thomas MS Ramdath, D Dan |
author_facet | Padhi, Emily MT Blewett, Heather J Duncan, Alison M Guzman, Randolph P Hawke, Aileen Seetharaman, Koushik Tsao, Rong Wolever, Thomas MS Ramdath, D Dan |
author_sort | Padhi, Emily MT |
collection | PubMed |
description | Background: Soy protein may reduce coronary heart disease (CHD) risk by lowering LDL cholesterol, but few studies have assessed whether whole soy flour displays a similar effect. Objective: The aim of this study was to assess the dose effect of whole soy flour incorporated into muffins on plasma LDL cholesterol in hypercholesterolemic adults. Methods: Adults aged 30–70 y (n = 243) with elevated LDL cholesterol (≥3.0 and ≤5.0 mmol/L) were stratified by LDL cholesterol and randomly assigned to consume 2 soy muffins containing 25 g soy protein [high-dose soy (HDS)], 1 soy and 1 wheat muffin containing 12.5 g soy protein and 12.5 g whey protein [low-dose soy (LDS)], or 2 wheat muffins containing 25 g whey protein (control) daily for 6 wk while consuming a self-selected diet. Fasting blood samples were collected at weeks 0, 3, and 6 for analysis of plasma lipids [total, LDL, and HDL cholesterol and triglycerides (TGs)], glucose, insulin, C-reactive protein (CRP), and isoflavones. Blood pressures also were measured. Dietary intake was assessed at weeks 0 and 4 with the use of 3 d food records. Treatment effects were assessed with the use of intention-to-treat analysis with multiple imputation and LDL cholesterol as the primary outcome. Results: In total, 213 (87.6%) participants completed the trial. Participants were primarily Caucasian (83%) and mostly female (63%), with a mean ± SD body mass index (in kg/m(2)) of 28.0 ± 4.6 and systolic and diastolic blood pressures of 122 ± 16 and 77 ± 11 mm Hg, respectively. Despite a dose-dependent increase in plasma isoflavones (P < 0.001), neither HDS nor LDS had a significant effect on LDL cholesterol compared with control (mean ± SEM changes: control, −0.04 ± 0.05 mmol/L; HDS, 0.01 ± 0.05 mmol/L; and LDS, −0.04 ± 0.06 mmol/L). There were no significant treatment effects on total or HDL cholesterol, TGs, CRP, homeostatic model assessment of insulin resistance, blood pressure, or the Framingham 10-y CHD risk score. Conclusion: Consuming 12.5 or 25 g protein from defatted soy flour incorporated into muffins does not reduce LDL cholesterol or other CHD risk factors in hypercholesterolemic adults. This trial was registered at clinicaltrials.gov as NCT01547585. |
format | Online Article Text |
id | pubmed-4656908 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | American Society for Nutrition |
record_format | MEDLINE/PubMed |
spelling | pubmed-46569082015-12-03 Whole Soy Flour Incorporated into a Muffin and Consumed at 2 Doses of Soy Protein Does Not Lower LDL Cholesterol in a Randomized, Double-Blind Controlled Trial of Hypercholesterolemic Adults(1)(2) Padhi, Emily MT Blewett, Heather J Duncan, Alison M Guzman, Randolph P Hawke, Aileen Seetharaman, Koushik Tsao, Rong Wolever, Thomas MS Ramdath, D Dan J Nutr Nutrition and Disease Background: Soy protein may reduce coronary heart disease (CHD) risk by lowering LDL cholesterol, but few studies have assessed whether whole soy flour displays a similar effect. Objective: The aim of this study was to assess the dose effect of whole soy flour incorporated into muffins on plasma LDL cholesterol in hypercholesterolemic adults. Methods: Adults aged 30–70 y (n = 243) with elevated LDL cholesterol (≥3.0 and ≤5.0 mmol/L) were stratified by LDL cholesterol and randomly assigned to consume 2 soy muffins containing 25 g soy protein [high-dose soy (HDS)], 1 soy and 1 wheat muffin containing 12.5 g soy protein and 12.5 g whey protein [low-dose soy (LDS)], or 2 wheat muffins containing 25 g whey protein (control) daily for 6 wk while consuming a self-selected diet. Fasting blood samples were collected at weeks 0, 3, and 6 for analysis of plasma lipids [total, LDL, and HDL cholesterol and triglycerides (TGs)], glucose, insulin, C-reactive protein (CRP), and isoflavones. Blood pressures also were measured. Dietary intake was assessed at weeks 0 and 4 with the use of 3 d food records. Treatment effects were assessed with the use of intention-to-treat analysis with multiple imputation and LDL cholesterol as the primary outcome. Results: In total, 213 (87.6%) participants completed the trial. Participants were primarily Caucasian (83%) and mostly female (63%), with a mean ± SD body mass index (in kg/m(2)) of 28.0 ± 4.6 and systolic and diastolic blood pressures of 122 ± 16 and 77 ± 11 mm Hg, respectively. Despite a dose-dependent increase in plasma isoflavones (P < 0.001), neither HDS nor LDS had a significant effect on LDL cholesterol compared with control (mean ± SEM changes: control, −0.04 ± 0.05 mmol/L; HDS, 0.01 ± 0.05 mmol/L; and LDS, −0.04 ± 0.06 mmol/L). There were no significant treatment effects on total or HDL cholesterol, TGs, CRP, homeostatic model assessment of insulin resistance, blood pressure, or the Framingham 10-y CHD risk score. Conclusion: Consuming 12.5 or 25 g protein from defatted soy flour incorporated into muffins does not reduce LDL cholesterol or other CHD risk factors in hypercholesterolemic adults. This trial was registered at clinicaltrials.gov as NCT01547585. American Society for Nutrition 2015-12 2015-10-07 /pmc/articles/PMC4656908/ /pubmed/26446482 http://dx.doi.org/10.3945/jn.115.219873 Text en http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the CC-BY license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Nutrition and Disease Padhi, Emily MT Blewett, Heather J Duncan, Alison M Guzman, Randolph P Hawke, Aileen Seetharaman, Koushik Tsao, Rong Wolever, Thomas MS Ramdath, D Dan Whole Soy Flour Incorporated into a Muffin and Consumed at 2 Doses of Soy Protein Does Not Lower LDL Cholesterol in a Randomized, Double-Blind Controlled Trial of Hypercholesterolemic Adults(1)(2) |
title | Whole Soy Flour Incorporated into a Muffin and Consumed at 2 Doses of Soy Protein Does Not Lower LDL Cholesterol in a Randomized, Double-Blind Controlled Trial of Hypercholesterolemic Adults(1)(2) |
title_full | Whole Soy Flour Incorporated into a Muffin and Consumed at 2 Doses of Soy Protein Does Not Lower LDL Cholesterol in a Randomized, Double-Blind Controlled Trial of Hypercholesterolemic Adults(1)(2) |
title_fullStr | Whole Soy Flour Incorporated into a Muffin and Consumed at 2 Doses of Soy Protein Does Not Lower LDL Cholesterol in a Randomized, Double-Blind Controlled Trial of Hypercholesterolemic Adults(1)(2) |
title_full_unstemmed | Whole Soy Flour Incorporated into a Muffin and Consumed at 2 Doses of Soy Protein Does Not Lower LDL Cholesterol in a Randomized, Double-Blind Controlled Trial of Hypercholesterolemic Adults(1)(2) |
title_short | Whole Soy Flour Incorporated into a Muffin and Consumed at 2 Doses of Soy Protein Does Not Lower LDL Cholesterol in a Randomized, Double-Blind Controlled Trial of Hypercholesterolemic Adults(1)(2) |
title_sort | whole soy flour incorporated into a muffin and consumed at 2 doses of soy protein does not lower ldl cholesterol in a randomized, double-blind controlled trial of hypercholesterolemic adults(1)(2) |
topic | Nutrition and Disease |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656908/ https://www.ncbi.nlm.nih.gov/pubmed/26446482 http://dx.doi.org/10.3945/jn.115.219873 |
work_keys_str_mv | AT padhiemilymt wholesoyflourincorporatedintoamuffinandconsumedat2dosesofsoyproteindoesnotlowerldlcholesterolinarandomizeddoubleblindcontrolledtrialofhypercholesterolemicadults12 AT blewettheatherj wholesoyflourincorporatedintoamuffinandconsumedat2dosesofsoyproteindoesnotlowerldlcholesterolinarandomizeddoubleblindcontrolledtrialofhypercholesterolemicadults12 AT duncanalisonm wholesoyflourincorporatedintoamuffinandconsumedat2dosesofsoyproteindoesnotlowerldlcholesterolinarandomizeddoubleblindcontrolledtrialofhypercholesterolemicadults12 AT guzmanrandolphp wholesoyflourincorporatedintoamuffinandconsumedat2dosesofsoyproteindoesnotlowerldlcholesterolinarandomizeddoubleblindcontrolledtrialofhypercholesterolemicadults12 AT hawkeaileen wholesoyflourincorporatedintoamuffinandconsumedat2dosesofsoyproteindoesnotlowerldlcholesterolinarandomizeddoubleblindcontrolledtrialofhypercholesterolemicadults12 AT seetharamankoushik wholesoyflourincorporatedintoamuffinandconsumedat2dosesofsoyproteindoesnotlowerldlcholesterolinarandomizeddoubleblindcontrolledtrialofhypercholesterolemicadults12 AT tsaorong wholesoyflourincorporatedintoamuffinandconsumedat2dosesofsoyproteindoesnotlowerldlcholesterolinarandomizeddoubleblindcontrolledtrialofhypercholesterolemicadults12 AT woleverthomasms wholesoyflourincorporatedintoamuffinandconsumedat2dosesofsoyproteindoesnotlowerldlcholesterolinarandomizeddoubleblindcontrolledtrialofhypercholesterolemicadults12 AT ramdathddan wholesoyflourincorporatedintoamuffinandconsumedat2dosesofsoyproteindoesnotlowerldlcholesterolinarandomizeddoubleblindcontrolledtrialofhypercholesterolemicadults12 |